Please visit answersincme.com/BHU860 to participate, download slides and supporting materials, complete the post test, and obtain credit. In this activity, an expert in lymphoma discusses the treatment landscape for CD30-positive peripheral T-cell lymphoma (PTCL). Upon completion of this activity, participants should be better able to: Review the latest guideline recommendations for frontline treatment of PTCL; Describe the clinical evidence informing the use of CD30-directed therapy in frontline treatment of PTCL; and Outline considerations to optimize outcomes with CD30-directed therapy for frontline treatment of patients with PTCL.
Fler avsnitt av CME in Minutes: Education in Primary Care
Visa alla avsnitt av CME in Minutes: Education in Primary CareCME in Minutes: Education in Primary Care med Answers in CME finns tillgänglig på flera plattformar. Informationen på denna sida kommer från offentliga podd-flöden.
